WRAP53 (WD repeat containing, antisense to TP53)

2010-11-01   Marianne Farnebo 

Karolinska Institutet, Cancer Center Karolinska (CCK) R8 :04, 17176 Stockholm, Sweden

Identity

HGNC
LOCATION
17p13.1
LOCUSID
ALIAS
DKCB3,TCAB1,WDR79
FUSION GENES

DNA/RNA

Description

The WRAP53 gene encompasses 16 kb of DNA; 13 exons (three non-coding alternative start exons: exon 1alpha, 1beta and 1gamma. Exon 1alpha directly overlaps the first exon of TP53 in an antisense fashion by up to 227 base pairs (bp), depending on transcription start site (TSS) usage. Exon 1gamma of WRAP53 is located in the first intron of TP53 overlapping the previously identified transcript Hp53int1 in an antisense fashion.

Transcription

At least 17 splice variants. 1.9 kb mRNA; 1647 bp open reading frame.

Regulatory antisense RNA
Expression: widely expressed at low levels.
Localisation: cytoplasm and nucleus.
Function: regulates p53 mRNA levels by interacting with the 5UTR of p53 mRNA.
Homology: conserved in mouse.
Diseases implication currently not analysed.

Pseudogene

Not known.

Proteins

Description

548 amino acids; 75 kDa protein; contains from N-term to C-term, a proline-rich region (aa 8-57), a WD40 domain, 5 repeats (160-441), and a glycin-rich region (533-545).

Expression

Widely expressed, overexpressed in cancer.

Localisation

Cytoplasm and nucleus (enriched in Cajal bodies).

Function

Essential for Cajal body formation and maintenance. Targets the SMN complex, scaRNAs and telomerase enzyme (via TERC) to Cajal bodies. Inhibition of WRAP53 triggers mitochondrial-dependent apoptosis specifically in cancer cells.

Homology

Highly-conserved in mammals, the WD40 domain is conserved from human to fly.

Mutations

Note

Single nucleotide polymorphisms (SNPs) in women with breast cancer (see below).

Germinal

Not reported.

Somatic

Not reported.

Implicated in

Entity name
Breast and ovarian cancer
Note
Single nucleotide polymorphisms (SNPs) in WRAP53 were found to be overrepresented in women with breast cancer, in particular estrogen receptor negative breast cancer. The same SNPs were also associated with aggressive ovarian cancer. The SNPs are located in the coding region of WRAP53 and results in the amino acid change R68G.
Entity name
Spinal muscular atrophy (SMA)
Note
WRAP53 targets the SMN complex to Cajal Bodies. WRAP53 and SMN association is disrupted in SMA patients suggesting a role of WRAP53 in SMA pathogenesis.
Disease
Spinal muscular atrophy (SMA) is a common neurodegenerative disorder caused by reduced levels of SMN due to mutations or deletions of the SMN1 gene. SMA is the leading genetic cause of infant mortality worldwide, affecting approximately 1 in 6000 infants.

Bibliography

Pubmed IDLast YearTitleAuthors
176830732007Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.Garcia-Closas M et al
192763752009Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.Schildkraut JM et al
192854452009A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles.Tycowski KT et al
191795342009A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.Venteicher AS et al

Other Information

Locus ID:

NCBI: 55135
MIM: 612661
HGNC: 25522
Ensembl: ENSG00000141499

Variants:

dbSNP: 55135
ClinVar: 55135
TCGA: ENSG00000141499
COSMIC: WRAP53

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000141499ENST00000316024Q9BUR4
ENSG00000141499ENST00000396463Q9BUR4
ENSG00000141499ENST00000431639Q9BUR4
ENSG00000141499ENST00000457584Q9BUR4
ENSG00000141499ENST00000463804K7EJ50
ENSG00000141499ENST00000498311E9PMR3
ENSG00000141499ENST00000534050E9PMG4

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Metabolism of proteinsREACTOMER-HSA-392499
Protein foldingREACTOMER-HSA-391251
Chaperonin-mediated protein foldingREACTOMER-HSA-390466
Association of TriC/CCT with target proteins during biosynthesisREACTOMER-HSA-390471
Cell CycleREACTOMER-HSA-1640170
Chromosome MaintenanceREACTOMER-HSA-73886
Telomere MaintenanceREACTOMER-HSA-157579
Extension of TelomeresREACTOMER-HSA-180786
Telomere Extension By TelomeraseREACTOMER-HSA-171319

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
191795342009A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.220
212058632011Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.103
192509072009Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage.102
210722402010WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.61
225476742012Telomerase recruitment requires both TCAB1 and Cajal bodies independently.55
265513492016Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.36
254674442014Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1.35
186766802008Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.32
255125602014The scaffold protein WRAP53β orchestrates the ubiquitin response critical for DNA double-strand break repair.27
196921682010Genetic susceptibility to distinct bladder cancer subphenotypes.25

Citation

Marianne Farnebo

WRAP53 (WD repeat containing, antisense to TP53)

Atlas Genet Cytogenet Oncol Haematol. 2010-11-01

Online version: http://atlasgeneticsoncology.org/gene/50705/wrap53